tiprankstipranks
Trending News
More News >
Herbalife Ltd (HLF)
NYSE:HLF
Advertisement

Herbalife (HLF) AI Stock Analysis

Compare
499 Followers

Top Page

HLF

Herbalife

(NYSE:HLF)

Rating:72Outperform
Price Target:
$10.50
▲(14.63% Upside)
Herbalife's overall stock score reflects a combination of strong valuation and positive technical indicators, offset by financial performance concerns. The earnings call provided a positive outlook with enhanced guidance, but challenges in specific regions and high financial leverage remain significant risks.
Positive Factors
Acquisitions
Herbalife announced it entered into a binding agreement to acquire Pro2col Health, LinkBiosciences, and Pruvit Venture, which could become a powerful tool to improve engagement and retention of customers and increase distributor productivity.
Distributor Growth
Initiatives in recognition, digital tools, and distributor training have led to significant growth in new and total distributors.
Leadership
New CEO Stephan Gratziani has a long-term vision and connects with top distributors, contributing positively to the company's future.
Negative Factors
Macro Pressures
Macro pressures present hurdles across multiple geographies, affecting new distributor productivity.
Regional Challenges
Revenue remains shaky with volume points growing in just one region while three others declined.
Web Traffic
Globally, the trends across web & app traffic have been consistently weak with a notable worsening in average unique visitors to myherbalife.com.

Herbalife (HLF) vs. SPDR S&P 500 ETF (SPY)

Herbalife Business Overview & Revenue Model

Company DescriptionHerbalife Nutrition Ltd. offers nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and rest of Asia Pacific. The company provides products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. It offers weight management products, including meal replacement products, protein shakes, drink mixes, weight loss enhancers, and healthy snacks; targeted nutrition products, which comprise functional beverages, and dietary and nutritional supplements that contain herbs, vitamins, minerals, and other natural ingredients; outer nutrition products, such as facial skin, body, and hair care products; and energy, sports, and fitness products, including N-R-G tea and energy drink products. The company also provides literature, promotional, and other materials that comprise start-up kits, sales tools, and educational materials. It offers its products through independent service providers and sales representatives, as well as through company-operated retail platforms. The company was formerly known as Herbalife Ltd. and changed its name to Herbalife Nutrition Ltd. in April 2018. Herbalife Nutrition Ltd. was founded in 1980 and is headquartered in Los Angeles, California.
How the Company Makes MoneyHerbalife generates revenue primarily through the sale of its products, which are distributed by independent distributors who earn commissions based on their sales and the sales of their recruits. This MLM structure creates multiple revenue streams: direct sales to consumers, commissions from distributor sales, and bonuses for distributors based on their sales performance and team sales. Additionally, Herbalife benefits from retail sales through its branded stores and online platforms. The company's earnings are also influenced by promotional partnerships and sponsorships within the fitness and wellness industries, reinforcing its brand presence and driving product demand.

Herbalife Earnings Call Summary

Earnings Call Date:Aug 06, 2025
(Q2-2025)
|
% Change Since: -0.97%|
Next Earnings Date:Oct 29, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted significant product innovation and positive momentum in North America, with strong distributor engagement and financial performance exceeding guidance. However, the company faced challenges with a decline in net sales and specific regional difficulties in EMEA and China.
Q2-2025 Updates
Positive Updates
New Product Launches and Innovation
Herbalife launched MultiBurn, a nonpharmaceutical weight loss supplement, and entered a new category with its first healthy lifespan product. The company is also integrating Link Biosciences for personalized nutritional supplements.
Positive Trends in North America
July marked the first month of year-over-year volume growth in North America since April 2021, contributing to a raised full-year net sales guidance range.
Strong Distributor Engagement
Distributor engagement was high, with nearly 38,000 attendees at Extravaganza training events. Enthusiasm was particularly strong in North America, with 7,000 distributors signing up for the Pro2col beta program.
Financial Performance Exceeds Guidance
Adjusted EBITDA exceeded guidance at $174 million, and the company paid down $55 million in debt, maintaining a total leverage ratio of 3x.
Negative Updates
Decline in Net Sales
Net sales were $1.3 billion, down 1.7% versus Q2 of 2024, with a 3.1% decline in overall volume year-over-year.
Challenges in EMEA and China
EMEA net sales were flat, and China saw a 2% decline in net sales year-over-year, with a 6% decline in volumes.
Company Guidance
During the Second Quarter 2025 Earnings Conference Call, Herbalife Limited provided guidance and insights into its ongoing transformation into a data-driven wellness company. The company reported net sales of $1.3 billion, a decrease of 1.7% compared to Q2 2024, but noted that on a constant currency basis, sales were flat year-over-year. Herbalife's adjusted EBITDA exceeded guidance at $174 million, with an adjusted EBITDA margin of 13.8%. The company highlighted significant initiatives, including the launch of its Pro2col app and the introduction of MultiBurn, a nonpharmaceutical weight loss supplement. Herbalife paid down $55 million in debt, maintaining a total leverage ratio of 3x as of June 30. The call also detailed the global momentum, particularly in North America, where July marked the first month of year-over-year volume growth since April 2021. With enhanced guidance for the full year, Herbalife anticipates net sales growth between down 1% to up 3%, both on a reported and constant currency basis.

Herbalife Financial Statement Overview

Summary
Herbalife's financial performance is mixed. Strong gross profit margins indicate efficient cost management, but declining revenue and net profit margins highlight challenges in sustaining growth. The balance sheet shows significant financial leverage and negative equity, posing risks to financial stability. Cash flow generation is stable, but high financing outflows suggest potential liquidity pressures.
Income Statement
70
Positive
Herbalife's income statement shows a declining trend in total revenue over the past few years, with a recent TTM total revenue of $4.95 billion, down from $5.20 billion in 2022. The gross profit margin remains strong at approximately 77.39% for the TTM period, indicating efficient cost management. However, the net profit margin has decreased to 5.66% from higher levels in previous years, highlighting challenges in maintaining profitability. The EBIT margin for TTM stands at 9.08%, and EBITDA margin at 10.64%, both reflecting a stable yet pressured operating environment.
Balance Sheet
45
Neutral
The balance sheet reveals significant financial leverage, with a negative stockholders' equity of -$736 million as of TTM, indicating high debt levels relative to assets. The debt-to-equity ratio is not calculable due to negative equity, raising concerns about financial stability. The equity ratio is also negative, further emphasizing the risk associated with high indebtedness. Despite these challenges, total assets remain substantial at $2.68 billion.
Cash Flow
65
Positive
Herbalife's cash flow statement shows a modest free cash flow growth, with TTM free cash flow of $164.4 million, slightly higher than the previous year's $163.4 million. The operating cash flow to net income ratio is 0.97, indicating efficient cash conversion from net income. However, the high levels of financing cash outflows raise concerns about reliance on debt to fund operations.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue4.95B4.99B5.06B5.20B5.80B5.54B
Gross Profit3.83B3.89B3.87B4.03B4.56B4.39B
EBITDA560.40M509.10M482.20M672.70M854.60M740.90M
Net Income280.40M254.30M142.20M321.30M447.20M372.60M
Balance Sheet
Total Assets2.68B2.73B2.81B2.73B2.82B3.08B
Cash, Cash Equivalents and Short-Term Investments329.40M415.30M575.20M508.00M601.50M1.05B
Total Debt2.40B2.47B2.77B2.88B2.96B2.64B
Total Liabilities3.42B3.53B3.87B4.00B4.21B3.93B
Stockholders Equity-736.00M-801.10M-1.06B-1.27B-1.39B-856.10M
Cash Flow
Free Cash Flow164.40M163.40M222.50M196.10M308.90M516.60M
Operating Cash Flow271.80M285.40M357.50M352.50M460.30M628.60M
Investing Cash Flow-70.60M-84.60M-134.80M-156.20M-156.40M-123.20M
Financing Cash Flow-249.30M-335.30M-148.30M-264.70M-728.60M-320.90M

Herbalife Technical Analysis

Technical Analysis Sentiment
Positive
Last Price9.16
Price Trends
50DMA
8.94
Positive
100DMA
8.13
Positive
200DMA
7.69
Positive
Market Momentum
MACD
-0.02
Positive
RSI
49.39
Neutral
STOCH
43.88
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HLF, the sentiment is Positive. The current price of 9.16 is below the 20-day moving average (MA) of 9.37, above the 50-day MA of 8.94, and above the 200-day MA of 7.69, indicating a neutral trend. The MACD of -0.02 indicates Positive momentum. The RSI at 49.39 is Neutral, neither overbought nor oversold. The STOCH value of 43.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HLF.

Herbalife Risk Analysis

Herbalife disclosed 33 risk factors in its most recent earnings report. Herbalife reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Herbalife Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
$2.92B20.348.22%14.22%-1.81%
72
Outperform
$918.67M2.80-31.74%-2.25%288.79%
72
Outperform
$283.93M21.599.15%4.33%-6.33%
70
Outperform
$535.73M16.276.54%2.75%-37.25%
65
Neutral
$1.97B15.358.70%-4.90%0.29%
62
Neutral
HK$21.76B9.905.51%4.90%1.24%-22.96%
61
Neutral
$2.12B25.338.79%2.85%0.50%-4.46%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HLF
Herbalife
9.16
1.49
19.43%
CENT
Central Garden Pet
35.24
-3.34
-8.66%
JJSF
J & J Snack Foods
112.80
-53.03
-31.98%
SMPL
Simply Good Foods
29.09
-3.44
-10.57%
NATR
Nature's Sunshine Products
16.28
3.24
24.85%
USNA
USANA Health
30.07
-8.45
-21.94%

Herbalife Corporate Events

Product-Related AnnouncementsBusiness Operations and StrategyFinancial Disclosures
Herbalife Reports Q2 2025 Financial Results and Innovations
Positive
Aug 6, 2025

Herbalife reported its financial results for the second quarter of 2025, with net sales of $1.3 billion, slightly down by 1.7% compared to the previous year, impacted by foreign currency headwinds. The company exceeded its adjusted EBITDA guidance and raised its full-year net sales and adjusted EBITDA outlook. Recent developments include the launch of MultiBurn, a new weight-loss supplement, and the unveiling of the beta version of the Pro2col app, indicating a focus on innovation and expanding product offerings. These initiatives, along with strong distributor engagement programs, are expected to drive future growth and enhance Herbalife’s market position.

The most recent analyst rating on (HLF) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Herbalife stock, see the HLF Stock Forecast page.

Private Placements and FinancingFinancial Disclosures
Herbalife Announces Redemption of Senior Notes
Neutral
Jun 16, 2025

On June 10, 2025, Herbalife Ltd. and its subsidiary issued a notice to redeem $50 million of their 7.875% Senior Notes due 2025. The redemption is scheduled for June 30, 2025, at a price of $1,000 per $1,000 principal amount, impacting the company’s financial obligations and potentially its market positioning.

The most recent analyst rating on (HLF) stock is a Hold with a $11.00 price target. To see the full list of analyst forecasts on Herbalife stock, see the HLF Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 07, 2025